You are here

2017 Publications

Allam A, Peachman KK, Aguilera-Olvera R, Casares S, Rao M. Isolation of human lymphocytes with high yield and viability from the gastrointestinal and female reproductive tract of a humanized DRAG mouse. J Immunol Methods. 2017 Dec 24. pii: S0022-1759(17)30351-4. doi: 10.1016/j.jim.2017.12.004. [Epub ahead of print]. PMID: 29278684.

Torres OB, Matyas GR, Rao M, Peachman KK, Jalah R, Beck Z, Michael NL, Rice KC, Jacobson AE, Alving CR. Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant. NPJ Vaccines. 2017 May 2;2:13. doi: 10.1038/s41541-017-0013-9. eCollection 2017. PMID: 29263870.

Seaton KE, Vandergrift NA, Deal AW, Rountree W, Bainbridge J, Grebe E, Anderson DA, Sawant S, Shen X, Yates NL, Denny TN, Liao HX, Haynes BF, Robb ML, Parkin N, Santos BR, Garrett N, Price MA, Naniche D, Duerr AC; CEPHIA group, Keating S, Hampton D, Facente S, Marson K, Welte A, Pilcher CD, Cohen MS, Tomaras GD. Computational analysis of antibody dynamics identifies recent HIV-1 infection. JCI Insight. 2017 Dec 21;2(24). pii: 94355. doi: 10.1172/jci.insight.94355. [Epub ahead of print]. PMID: 29263306.

Singh P, Li R. Emerging roles for sphingolipids in cellular aging. Curr Genet. 2017 Dec 19. doi: 10.1007/s00294-017-0799-z. [Epub ahead of print] Review. PMID: 29260307.

Matavele Chissumba R, Namalango E, Maphossa V, Macicame I, Bhatt N, Polyak C, Robb M, Michael N, Jani I, Kestens L. Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection. BMC Immunol. 2017 Dec 16;18(1):50. doi: 10.1186/s12865-017-0235-7. PMID: 29246111.

Herbeck JT, Peebles K, Edlefsen PT, Rolland M, Murphy JT, Gottlieb GS, Abernethy N, Mullins JI, Mittler JE, Goodreau SM. HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. Vaccine. 2017 Dec 11. pii: S0264-410X(17)31731-0. doi: 10.1016/j.vaccine.2017.12.004. [Epub ahead of print]. PMID: 29241646.

Sulima A, Jalah R, Antoline JFG, Torres OB, Imler GH, Deschamps JR, Beck Z, Alving CR, Jacobson AE, Rice KC, Matyas GR. A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse. J Med Chem. 2017 Dec 29. doi: 10.1021/acs.jmedchem.7b01427. [Epub ahead of print]. PMID: 29236495.

Crowell TA, Colby DJ, Pinyakorn S, Fletcher JLK, Kroon E, Schuetz A, Krebs SJ, Slike BM, Leyre L, Chomont N, Jagodzinski LL, Sereti I, Utay NS, Dewar R, Rerknimitr R, Chomchey N, Trichavaroj R, Valcour VG, Spudich S, Michael NL, Robb ML, Phanuphak N, Ananworanich J; RV254/SEARCH010 Study Group. Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments. Clin Infect Dis. 2017 Dec 7. doi: 10.1093/cid/cix1063. [Epub ahead of print]. PMID: 29228130.

Michael NL. Clinical trial design: The nobility of randomization. Sci Transl Med. 2017 Dec 6;9(419). pii: eaaq0810. doi: 10.1126/scitranslmed.aaq0810. Review. PMID: 29212710.

Modjarrad K, Vermund SH. Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region Comment on "Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward". Int J Health Policy Manag. 2017 May 22;6(12):729-732. doi: 10.15171/ijhpm.2017.53. PMID: 29172382.

Rodriguez-Hart C, Musci R, Nowak RG, German D, Orazulike I, Ononaku U, Liu H, Crowell TA, Baral S, Charurat M; TRUST/RV368 Study Group. Sexual Stigma Patterns Among Nigerian Men Who Have Sex with Men and Their Link to HIV and Sexually Transmitted Infection Prevalence. AIDS Behav. 2017 Nov 22. doi: 10.1007/s10461-017-1982-4. [Epub ahead of print]. PMID: 29168069.

Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, Reyes Teran G, Mallal S, John M, Buchbinder S, Kirk G, Martin J, Michael N, Fellay J, Deeks S, Walker B, Avila-Rios S, Cole D, Brander C, Carrington M, Goulder P. DIFFERENTIAL IMMUNODOMINANCE HIERARCHY OF CD8+ T CELL RESPONSES IN HLA-B*27:05 AND B*27:02-MEDIATED CONTROL OF HIV-1 INFECTION. J Virol. 2017 Nov 22. pii: JVI.01685-17. doi: 10.1128/JVI.01685-17. [Epub ahead of print]. PMID: 29167337.

Kim J, Peachman KK, Jobe O, Morrison EB, Allam A, Jagodzinski L, Casares SA, Rao M. Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model. Front Immunol. 2017 Oct 27;8:1405. doi: 10.3389/fimmu.2017.01405. eCollection 2017. PMID: 29163484.

deCamp AC, Rolland M, Edlefsen PT, Sanders-Buell E, Hall B, Magaret CA, Fiore-Gartland AJ, Juraska M, Carpp LN, Karuna ST, Bose M, LePore S, Miller S, O'Sullivan A, Poltavee K, Bai H, Dommaraju K, Zhao H, Wong K, Chen L, Ahmed H, Goodman D, Tay MZ, Gottardo R, Koup RA, Bailer R, Mascola JR, Graham BS, Roederer M, O'Connell RJ, Michael NL, Robb ML, Adams E, D'Souza P, Kublin J, Corey L, Geraghty DE, Frahm N, Tomaras GD, McElrath MJ, Frenkel L, Styrchak S, Tovanabutra S, Sobieszczyk ME, Hammer SM, Kim JH, Mullins JI, Gilbert PB. Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120. PLoS One. 2017 Nov 17;12(11):e0185959. doi: 10.1371/journal.pone.0185959. eCollection 2017. PMID: 29149197.

Chomont N, Okoye AA, Favre D, Trautmann L. Wake me up before you go: A strategy to reduce the latent HIV reservoir. AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001695. [Epub ahead of print]. PMID: 29135580.

Jobe O, Kim J, Tycksen E, Onkar S, Michael NL, Alving CR, Rao M. Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection. Front Immunol. 2017 Oct 23;8:1352. doi: 10.3389/fimmu.2017.01352. eCollection 2017. PMID: 29123518.

Pardo G, Saisaengjan C, Gopalan P, Ananworanich J, Lakhonpon S, Nestadt DF, Bunupuradah T, Mellins CA, McKay MM. Cultural Adaptation of an Evidence-Informed Psychosocial Intervention to Address the Needs of PHIV+ Youth in Thailand. Glob Soc Welf. 2017;4(4):209-218. doi: 10.1007/s40609-017-0100-x. Epub 2017 Jul 24. PMID: 29104848.

Hsu DC, Ananworanich J. Immune Interventions to Eliminate the HIV Reservoir. Curr Top Microbiol Immunol. 2017 Oct 26. doi: 10.1007/82_2017_70. [Epub ahead of print]. PMID: 29071472.

Harbertson J, Jamerson M, Graf PCF, Kennemur L, House B, Michael NL, Scott P, Hale B. Population-based Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis prevalence using discarded, deidentified urine specimens previously collected for drug testing. Sex Transm Infect. 2017 Oct 24. pii: sextrans-2017-053355. doi: 10.1136/sextrans-2017-053355. [Epub ahead of print] No abstract available. PMID: 29066630.

Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, Uyeki TM, Vallenas C, Norris SL, Fischer WA Nd, Fletcher TE, Levine AC, Reed P, Bausch DG, Gove S, Hall A, Shepherd S, Siemieniuk RA, Lamah MC, Kamara R, Nakyeyune P, Soka MJ, Edwin A, Hazzan AA, Jacob ST, Elkarsany MM, Adachi T, Benhadj L, Clément C, Crozier I, Garcia A, Hoffman SJ, Guyatt GH. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2017 Oct 17. pii: S0140-6736(17)31795-6. doi: 10.1016/S0140-6736(17)31795-6. [Epub ahead of print]. PMID: 29054555.

Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, Ho PT, Honeycutt JB, Fallahi M, Trautmann L, Garcia JV, Valente ST. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment. Cell Rep. 2017 Oct 17;21(3):600-611. doi: 10.1016/j.celrep.2017.09.080. PMID: 29045830.

Hakre S, Casimier RO, Danboise BA, Peel SA, Michael NL, Scott PT, Okulicz JF. Enhanced Sexually Transmitted Infection Screening for Mycoplasma genitalium in Human Immunodeficiency Virus -Infected US Air Force Personnel. Clin Infect Dis. 2017 Oct 16;65(9):1585-1588. doi: 10.1093/cid/cix555. PMID: 29020330.

Montalto GJ, Sawe FK, Miruka A, Maswai J, Kiptoo I, Aoko A, Oreyo C, Obiero E, Korir S, Bii SK, Song KX, Kunz AN. Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study. PLoS One. 2017 Oct 9;12(10):e0183180. doi: 10.1371/journal.pone.0183180. eCollection 2017. PMID: 28991913.

Viegas EO, Tembe N, Nilsson C, Meggi B, Maueia C, Augusto O, Stout R, Scarlatti G, Ferrari G, Earl PL, Wahren B, Andersson S, Robb ML, Osman N, Biberfeld G, Jani I, Sandström E. Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled Trial. AIDS Res Hum Retroviruses. 2017 Nov 27. doi: 10.1089/AID.2017.0121. [Epub ahead of print]. PMID: 28969431.

Ake JA, Schuetz A, Pegu P, Wieczorek L, Eller MA, Kibuuka H, Sawe F, Maboko L, Polonis V, Karasavva N, Weiner D, Sekiziyivu A, Kosgei J, Missanga M, Kroidl A, Mann P, Ratto-Kim S, Anne Eller L, Earl P, Moss B, Dorsey-Spitz J, Milazzo M, Laissa Ouedraogo G, Rizvi F, Yan J, Khan AS, Peel S, Sardesai NY, Michael NL, Ngauy V, Marovich M, Robb ML. Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost. J Infect Dis. 2017 Nov 27;216(9):1080-1090. doi: 10.1093/infdis/jix456. PMID: 28968759.

Liu F, Niu Q, Fan X, Liu C, Zhang J, Wei Z, Hou W, Kanneganti TD, Robb ML, Kim JH, Michael NL, Sun J, Soong L, Hu H. Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16-STING-Type I IFN Pathway and AIM2 Sensor. J Immunol. 2017 Nov 1;199(9):3293-3305. doi: 10.4049/jimmunol.1700698. Epub 2017 Sep 25. PMID: 28947539.

Rodriguez-Hart C, Nowak RG, Musci R, German D, Orazulike I, Kayode B, Liu H, Gureje O, Crowell TA, Baral S, Charurat M; TRUST/RV368 Study Group. Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian men who have sex with men. AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001637. [Epub ahead of print]. PMID: 28926403.

Teigler JE, Zelinskyy G, Eller MA, Bolton DL, Marovich M, Gordon AD, Alrubayyi A, Alter G, Robb ML, Martin JN, Deeks SG, Michael NL, Dittmer U, Streeck H. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection. J Virol. 2017 Sep 13. pii: JVI.01263-17. doi: 10.1128/JVI.01263-17. [Epub ahead of print]. PMID: 28904197.

Brett-Major DM, Crowell TA, Michael NL. Prospecting for an HIV vaccine. Trop Dis Travel Med Vaccines. 2017 Mar 24;3:6. doi: 10.1186/s40794-017-0050-4. eCollection 2017. Review. PMID: 28883976.

Brett-Major DM, Scott PT, Crowell TA, Polyak CS, Modjarrad K, Robb ML, Blazes DL. Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers. Trop Dis Travel Med Vaccines. 2016 Nov 28;2:25. doi: 10.1186/s40794-016-0042-9. eCollection 2016. Review. PMID: 28883969.

Ehrenberg PK, Geretz A, Sindhu RK, Vayntrub T, Fernández Viña MA, Apps R, Michael NL, Thomas R. High-throughput next-generation sequencing to genotype six classical HLA loci from 96 donors in a single MiSeq run. HLA. 2017 Aug 25. doi: 10.1111/tan.13133. [Epub ahead of print]. PMID: 28842944.

Volz EM, Ndembi N, Nowak R, Kijak GH, Idoko J, Dakum P, Royal W, Baral S, Dybul M, Blattner WA, Charurat M. Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics. Virus Evol. 2017 Jul 28;3(2):vex014. doi: 10.1093/ve/vex014. eCollection 2017 Jul. PMID: 28775893.

McCracken MK, Gromowski GD, Friberg HL, Lin X, Abbink P, De La Barrera R, Eckles KH, Garver LS, Boyd M, Jetton D, Barouch DH, Wise MC, Lewis BS, Currier JR, Modjarrad K, Milazzo M, Liu M, Mullins AB, Putnak JR, Michael NL, Jarman RG, Thomas SJ. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog. 2017 Aug 3;13(8):e1006487. doi: 10.1371/journal.ppat.1006487. eCollection 2017 Aug. PMID: 28771605. 

Kijak GH, Sanders-Buell E, Chenine AL, Eller MA, Goonetilleke N, Thomas R, Leviyang S, Harbolick EA, Bose M, Pham P, Oropeza C, Poltavee K, O'Sullivan AM, Billings E, Merbah M, Costanzo MC, Warren JA, Slike B, Li H, Peachman KK, Fischer W, Gao F, Cicala C, Arthos J, Eller LA, O'Connell RJ, Sinei S, Maganga L, Kibuuka H, Nitayaphan S, Rao M, Marovich MA, Krebs SJ, Rolland M, Korber BT, Shaw GM, Michael NL, Robb ML, Tovanabutra S, Kim JH. Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection. PLoS Pathog. 2017 Jul 31;13(7):e1006510. doi: 10.1371/journal.ppat.1006510. eCollection 2017 Jul. Erratum in: PLoS Pathog. 2017 Sep 14;13(9):e1006620. PMID: 28759651. 

Hakre S, Jagodzinski LL, Liu Y, Pham PT, Kijak GH, Tovanabutra S, McCutchan FE, Scoville SL, Cersovsky SB, Michael NL, Scott PT, Peel SA. Characteristics of HIV-infected U.S. Army soldiers linked in molecular transmission clusters, 2001-2012. PLoS One. 2017 Jul 31;12(7):e0182376. doi: 10.1371/journal.pone.0182376. eCollection 2017. PMID: 28759645. 

Landolt NK, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Kerr S, Boonyanurak P, Ananworanich J, Bunupuradah T. Strategies to improve the uptake of effective contraception in perinatally HIV-infected adolescents. J Virus Erad. 2017 Jul 1;3(3):152-156. PMID: 28758023. 

Chomchey N, Woratanarat T, Hiransuthikul N, Lertmaharit S, Lohsoonthorn V, Teeratakulpisarn N, Pinyakorn S, Fletcher JL, Suttichom D, Phanuphak P, Ananworanich J, Phanuphak N. Factors associated with intention to take non-occupational HIV post-exposure prophylaxis among Thai men who have sex with men. J Virus Erad. 2017 Jul 1;3(3):128-139. PMID: 28758020.

Hsu DC, Wegner MD, Sunyakumthorn P, Silsorn D, Tayamun S, Inthawong D, Kuncharin Y, Im-Erbsin R, Ege C, O'Connell RJ, Michael NL, Ndhlovu LC, Vasan S. CD4+ Cell infiltration into subcutaneous adipose tissue is not indicative of productively infected cells during acute SHIV infection. J Med Primatol. 2017 Aug;46(4):154-157. doi: 10.1111/jmp.12298. PMID: 28748665.

Farooq SA, Rasooly MH, Abidi SH, Modjarrad K, Ali S. Opium trade and the spread of HIV in the Golden Crescent. Harm Reduct J. 2017 Jul 21;14(1):47. doi: 10.1186/s12954-017-0170-1. Review. PMID: 28732503. 

Hinkula J, Petkov S, Ljungberg K, Hallengärd D, Bråve A, Isaguliants M, Falkeborn T, Sharma S, Liakina V, Robb M, Eller M, Moss B, Biberfeld G, Sandström E, Nilsson C, Markland K, Blomberg P, Wahren B. HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. Heliyon. 2017 Jun 29;3(6):e00339. doi: 10.1016/j.heliyon.2017.e00339. eCollection 2017 Jun. PMID: 28721397. 

Bauer A, Podola L, Mann P, Missanga M, Haule A, Sudi L, Nilsson C, Kaluwa B, Lueer C, Mwakatima M, Munseri PJ, Maboko L, Robb ML, Tovanabutra S, Kijak G, Marovich M, McCormack S, Joseph S, Lyamuya E, Wahren B, Sandström E, Biberfeld G, Hoelscher M, Bakari M, Kroidl A, Geldmacher C. Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen. J Virol. 2017 Aug 24;91(18). pii: e00730-17. doi: 10.1128/JVI.00730-17. Print 2017 Sep 15. PMID: 28701395.

Kroon EDMB, Phanuphak N, Shattock AJ, Fletcher JLK, Pinyakorn S, Chomchey N, Akapirat S, de Souza MS, Robb ML, Kim JH, van Griensven F, Ananworanich J, Wilson DP. Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok. J Int AIDS Soc. 2017 Jun 28;20(1):1-9. doi: 10.7448/IAS.20.1.21708. PMID: 28691441. 

Ananworanich J, Eller LA, Pinyakorn S, Kroon E, Sriplenchan S, Fletcher JL, Suttichom D, Bryant C, Trichavaroj R, Dawson P, Michael N, Phanuphak N, Robb ML. Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand. J Int AIDS Soc. 2017 Jun 26;20(1):1-7. doi: 10.7448/IAS.20.1.21652. PMID: 28691436. 

Rutstein SE, Ananworanich J, Fidler S, Johnson C, Sanders EJ, Sued O, Saez-Cirion A, Pilcher CD, Fraser C, Cohen MS, Vitoria M, Doherty M, Tucker JD. Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc. 2017 Jun 28;20(1):1-13. doi: 10.7448/IAS.20.1.21579. PMID: 28691435.

Harbertson J, Hale BR, Tran BR, Thomas AG, Grillo MP, Jacobs MB, McAnany J, Shaffer RA. Self-reported HIV-positive status but subsequent HIV-negative test result using rapid diagnostic testing algorithms among seven sub-Saharan African military populations. PLoS One. 2017 Jul 7;12(7):e0180796. doi: 10.1371/journal.pone.0180796. eCollection 2017. PMID: 28686678. 

Perez LG, Martinez DR, deCamp AC, Pinter A, Berman PW, Francis D, Sinangil F, Lee C, Greene K, Gao H, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, O'Connell RJ, Robb ML, Michael NL, Kim JH, Gilbert P, Montefiori DC. V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144. PLoS One. 2017 Jul 5;12(7):e0180720. doi: 10.1371/journal.pone.0180720. eCollection 2017. PMID: 28678869.

Bolton DL, McGinnis K, Finak G, Chattopadhyay P, Gottardo R, Roederer M. Combined single-cell quantitation of host and SIV genes and proteins ex vivo reveals host-pathogen interactions in individual cells. PLoS Pathog. 2017 Jun 27;13(6):e1006445. doi: 10.1371/journal.ppat.1006445. eCollection 2017 Jun. PMID: 28654687.

Genito CJ, Beck Z, Phares TW, Kalle F, Limbach KJ, Stefaniak ME, Patterson NB, Bergmann-Leitner ES, Waters NC, Matyas GR, Alving CR, Dutta S. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013. Vaccine. 2017 Jul 5;35(31):3865-3874. doi: 10.1016/j.vaccine.2017.05.070. Epub 2017 Jun 7.
PMID: 28596090.

Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, Sutherland LL, Phogat S, Tartaglia J, Reed SG, Hu SL, Theis JF, Pinter A, Montefiori DC, Kepler TB, Peachman KK, Rao M, Michael NL, Suscovich TJ, Alter G, Ackerman ME, Moody MA, Liao HX, Tomaras G, Ferrari G, Korber BT, Haynes BF. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nat Commun. 2017 Jun 8;8:15711. doi: 10.1038/ncomms15711. PMID: 28593989.

Lima NS, Rolland M, Modjarrad K, Trautmann L. T Cell Immunity and Zika Virus Vaccine Development. Trends Immunol. 2017 Aug;38(8):594-605. doi: 10.1016/j.it.2017.05.004. Epub 2017 Jun 1. Review. PMID: 28579320.

Chand S, Messina EL, AlSalmi W, Ananthaswamy N, Gao G, Uritskiy G, Padilla-Sanchez V, Mahalingam M, Peachman KK, Robb ML, Rao M, Rao VB. Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin. Virology. 2017 Aug;508:199-212. doi: 10.1016/j.virol.2017.05.016. Epub 2017 May 31. PMID: 28577856 Free Article

Kim J, Jobe O, Peachman KK, Michael NL, Robb ML, Rao M, Rao VB. Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies. Virology. 2017 Aug;508:188-198. doi: 10.1016/j.virol.2017.05.015. Epub 2017 May 31. PMID: 28577855.

Zhao M, Zheng ZZ, Chen M, Modjarrad K, Zhang W, Zhan LT, Cao JL, Sun YP, McLellan JS, Graham BS, Xia NS. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab. J Virol. 2017 Jul 12;91(15). pii: e00176-17. doi: 10.1128/JVI.00176-17. Print 2017 Aug 1. PMID: 28539438.

Babajide K, Ayemoba O, Terfa K, Ake J, Crowell TA, Adamu Y, Mohammed T, Okoye I, Odeyemi S, Crawford K, Hughes L, Akintunde E, Umar T, Hamm TE, Njoku OS. Virological Suppression and Patterns of Resistance Amongst Patients on Antiretroviral Therapy at 4 Nigerian Military Hospitals. Curr HIV Res. 2017;15(2):146-151. doi: 10.2174/1570162X15666170517103704. PMID: 28521719.

Shadyab A, Singer D, Hughes L, Nelson R, Umar T, Njoku OS. Building a Successful Military-to-Military Partnership through Confronting HIV: the U.S.-Nigeria Experience. Curr HIV Res. 2017 May 17. doi: 10.2174/1570162X15666170517122459. [Epub ahead of print]. PMID: 28521716.

Prasitsuebsai W, Sophonphan J, Chokephaibulkit K, Wongsawat J, Kanjanavanit S, Kosalaraksa P, Ngampiyakul C, Sangkla P, Hansudewechakul R, Kerr SJ, Puthanakit T, Ananworanich J; HIV-NAT 113 Study Group. Treatment Outcomes of Third-Line Antiretroviral Regimens in HIV-Infected Thai Adolescents. Pediatr Infect Dis J. 2017 May 16. doi: 10.1097/INF.0000000000001638. [Epub ahead of print]. PMID: 28520611.

Gilbert PB, Excler JL, Tomaras GD, Carpp LN, Haynes BF, Liao HX, Montefiori DC, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Kijak GH, Tovanabutra S, Francis DP, Lee C, Sinangil F, Berman PW, Premsri N, Kunasol P, O'Connell RJ, Michael NL, Robb ML, Morrow R, Corey L, Kim JH. Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One. 2017 May 11;12(5):e0176428. doi: 10.1371/journal.pone.0176428. eCollection 2017. PMID: 28493891.

Hellmuth J, Colby D, Valcour V, Suttichom D, Spudich S, Ananworanich J, Prueksakaew P, Sailasuta N, Allen I, Jagodzinski LL, Slike B, Ochi D, Paul R; RV254/SEARCH 010 Study Group. Depression and Anxiety are Common in Acute HIV Infection and Associate with Plasma Immune Activation. AIDS Behav. 2017 May 8. doi: 10.1007/s10461-017-1788-4. [Epub ahead of print]. PMID: 28484888.

Harausz EP, Leigh J, Garcia-Prats AJ, Furin J, Peloquin CA. Stability of Second-Line Tuberculosis Medications Mixed with Milk or Yogurt. Clin Infect Dis. 2017 May 6. doi: 10.1093/cid/cix434. [Epub ahead of print]. PMID: 28482036.

Buranapraditkun S, Pissani F, Teigler JE, Schultz BT, Alter G, Marovich M, Robb ML, Eller MA, Martin J, Deeks S, Michael NL, Streeck H. Preservation of peripheral T follicular helper cell function in HIV controllers. J Virol. 2017 May 3. pii: JVI.00497-17. doi: 10.1128/JVI.00497-17. [Epub ahead of print]. PMID: 28468877.

Crowell TA, Keshinro B, Baral SD, Schwartz SR, Stahlman S, Nowak RG, Adebajo S, Blattner WA, Charurat ME, Ake JA. Stigma, access to healthcare, and HIV risks among men who sell sex to men in Nigeria. J Int AIDS Soc. 2017 Apr 20;20(1):1-9. doi: 10.7448/IAS.20.01.21489. PMID: 28453241.

Sacdalan C, Crowell TA, Colby DJ, Kroon E, Chan P, Pinyakorn S, Chomchey N, Prueksakaew P, Puttamaswin S, Chintanaphol M, Cheng T, Phanuphak N, Ananworanich J; RV254/SEARCH 010 Study Group. Brief Report: Safety of frequent blood sampling in research participants in an acute HIV infection cohort in Thailand. J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001436. [Epub ahead of print]. PMID: 28452910.

Crowell TA, Lyall H, Malatinkova E, Bhagani S, Hsu D, Colby DJ, Polyak C, Psomas C, Hill A, Gathogo EN, Trypsteen W, Vandekerckhove L, Kinloch S. Highlights from the 24th Conference on Retroviruses and Opportunistic Infections: 13-16 February 2017, Seattle, Washington, USA. J Virus Erad. 2017 Apr 1;3(2):101-108. PMID: 28435696.

Vasan S, Wansom T, Schuetz A, Krebs S, Thomas R, Kijak G, Polyak C. Highlights from the HIV Research for Prevention Conference (R4P): 17-21 October 2016, Chicago, IL, USA. J Virus Erad. 2017 Apr 1;3(2):92-96. No abstract available. PMID: 28435694.

Garner SA, Rennie S, Ananworanich J, Dube K, Margolis DM, Sugarman J, Tressler R, Gilbertson A, Dawson L. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations. J Virus Erad. 2017 Apr 1;3(2):82-84. PMID: 28435691.

Robb ML, Bolton DL. Accessories to SIV Control: T Cell Vaccination Shows Potential. EBioMedicine. 2017 Apr;18:17-18. doi: 10.1016/j.ebiom.2017.04.012. Epub 2017 Apr 8. PMID: 28427945.

Manak MM, Eller LA, Malia J, Jagodzinski LL, Trichavaroj R, Oundo J, Lueer C, Cham F, de Souza M, Michael NL, Robb ML, Peel SA. Identification of acute HIV-1 infection by Hologic Aptima HIV-1 RNA Qualitative Assay. J Clin Microbiol. 2017 Apr 19. pii: JCM.00431-17. doi: 10.1128/JCM.00431-17. [Epub ahead of print]. PMID: 28424253.

Anand T, Nitpolprasert C, Trachunthong D, Kerr SJ, Janyam S, Linjongrat D, Hightow-Weidman LB, Phanuphak P, Ananworanich J, Phanuphak N. A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up. J Int AIDS Soc. 2017 Mar 10;20(1):1-11. doi: 10.7448/IAS.20.1.21326.
PMID: 28362062.

Falzon D, Schünemann HJ, Harausz E, González-Angulo L, Lienhardt C, Jaramillo E, Weyer K. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J. 2017 Mar 22;49(3). pii: 1602308. doi: 10.1183/13993003.02308-2016. Print 2017 Mar. PMID: 28331043. 

Rerks-Ngarm S, Pitisuttithum P, Excler JL, Nitayaphan S, Kaewkungwal J, Premsri N, Kunasol P, Karasavvas N, Schuetz A, Ngauy V, Sinangil F, Dawson P, deCamp AC, Phogat S, Garunathan S, Tartaglia J, DiazGranados C, Ratto-Kim S, Pegu P, Eller M, Karnasuat C, Montefiori DC, Sawant S, Vandergrift N, Wills S, Tomaras GD, Robb ML, Michael NL, Kim JH, Vasan S, O'Connell RJ; RV305 Study Team. Randomized, Double Blind Evaluation of Late Boost Strategies for HIV-uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial. J Infect Dis. 2017 Feb 21. doi: 10.1093/infdis/jix099. [Epub ahead of print]. PMID: 28329190.

Hsu DC, O'Connell RJ. Progress in HIV vaccine development. Hum Vaccin Immunother. 2017 May 4;13(5):1018-1030. doi: 10.1080/21645515.2016.1276138. Epub 2017 Mar 10. PMID: 28281871.

Kancheva Landolt N, Bunupuradah T, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Ubolyam S, Thammajaruk N, Kerr S, Ananworanich J. Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception. J Virus Erad. 2017 Jan 1;3(1):56-60. PMID: 28275459.

Seth L, Bingham Ferlez KM, Kaba SA, Musser DM, Emadi S, Matyas GR, Beck Z, Alving CR, Burkhard P, Lanar DE. Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants. Vaccine. 2017 Mar 6. pii: S0264-410X(17)30243-8. doi: 10.1016/j.vaccine.2017.02.040. [Epub ahead of print] PMID: 28274638. 

Ramadhani HO, Liu H, Nowak RG, Crowell TA, Ndomb T, Gaydos C, Peel S, Ndembi N, Baral SD, Ake J, Charurat ME; TRUST/RV368 Study Group. Sexual partner characteristics and incident rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections among gay men and other men who have sex with men (MSM): a prospective cohort in Abuja and Lagos, Nigeria. Sex Transm Infect. 2017 Feb 24. pii: sextrans-2016-052798. doi: 10.1136/sextrans-2016-052798. [Epub ahead of print]. PMID: 28235839.

Easterhoff D, Moody MA, Fera D, Cheng H, Ackerman M, Wiehe K, Saunders KO, Pollara J, Vandergrift N, Parks R, Kim J, Michael NL, O'Connell RJ, Excler JL, Robb ML, Vasan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Nitayaphan S, Sinangil F, Tartaglia J, Phogat S, Kepler TB, Alam SM, Liao HX, Ferrari G, Seaman MS, Montefiori DC, Tomaras GD, Harrison SC, Haynes BF. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. PLoS Pathog. 2017 Feb 24;13(2):e1006182. doi: 10.1371/journal.ppat.1006182. [Epub ahead of print]. PMID: 28235027.

Barouch DH, Thomas SJ, Michael NL. Prospects for a Zika Virus Vaccine. Immunity. 2017 Feb 21;46(2):176-182. doi: 10.1016/j.immuni.2017.02.005. Review. PMID: 28228277.

Agsalda-Garcia MA, Sithinamsuwan P, Valcour VG, Chalermchai T, Tipsuk S, Kuroda J, Nakamura C, Ananworanich J, Zhang G, Schuetz A, Slike BM, Shiramizu B; SEARCH 011 Study Group. Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):454-458. doi: 10.1097/QAI. 0000000000001259. PMID: 28225719.

Takata H, Buranapraditkun S, Kessing C, Fletcher JL, Muir R, Tardif V, Cartwright P, Vandergeeten C, Bakeman W, Nichols CN, Pinyakorn S, Hansasuta P, Kroon E, Chalermchai T, O'Connell R, Kim J, Phanuphak N, Robb ML, Michael NL, Chomont N, Haddad EK, Ananworanich J, Trautmann L; RV254/SEARCH010 and the RV304/SEARCH013 Study Groups. Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection. Sci Transl Med. 2017 Feb 15;9(377). pii: eaag1809. doi: 10.1126/scitranslmed.aag1809. PMID: 28202771.

Kessing CF, Spudich S, Valcour V, Cartwright P, Chalermchai T, Fletcher JL, Nichols C, Josey BJ, Slike B, Krebs SJ, Sailsuta N, Lerdlum S, Jagodzinski L, Tipsuk S, Suttichom D, Rattanamanee S, Zetterberg H, Hellmuth J, Phanuphak N, Robb ML, Michael NL, Ananworanich J, Trautmann L. High Number of Activated CD8+ T Cells Targeting HIV Antigens are Present in Cerebrospinal Fluid in Acute HIV Infection. J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001301. [Epub ahead of print]. PMID: 28177966.

Anand T, Nitpolprasert C, Kerr SJ, Muessig KE, Promthong S, Chomchey N, Hightow-Weidman LB, Chaiyahong P, Phanuphak P, Ananworanich J, Phanuphak N. A qualitative study of Thai HIV-positive young men who have sex with men and transgender women demonstrates the need for eHealth interventions to optimize the HIV care continuum. AIDS Care. 2017 Feb 3:1-6. doi: 10.1080/09540121.2017.1286288. [Epub ahead of print]. PMID: 28158952.

Huang Y, Zhang L, Janes H, Frahm N, Isaacs A, Kim JH, Montefiori D, McElrath MJ, Tomaras GD, Gilbert PB. Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials. Vaccine. 2017 Feb 22;35(8):1184-1193. doi: 10.1016/j.vaccine.2016.09.053. PMID: 28131393.

Nowak RG, Bentzen SM, Ravel J, Crowell TA, Dauda W, Ma B, Liu H, Blattner WA, Baral SD, Charurat ME; TRUSTRV368 Study Group. Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected men who have sex with men (MSM) in Nigeria. AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001409. [Epub ahead of print]. PMID: 28118207.

Prévost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, Brassard N, Parsons MS, Ruxrungtham K, Bunupuradah T, Tovanabutra S, Hwang KK, Moody MA, Haynes BF, Bonsignori M, Sodroski J, Kaufmann DE, Shaw GM, Chenine AL, Finzi A. Influence of the Envelope Gp120 Phe 43 Cavity on HIV-1 Sensitivity to ADCC Responses. J Virol. 2017 Jan 18. pii: JVI.02452-16. doi: 10.1128/JVI.02452-16. [Epub ahead of print]. PMID: 28100618.

Ottichilo RK, Polyak CS, Guyah B, Singa B, Nyataya J, Yuhas K, John-Stewart G, Waitumbi JN. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis. J Infect Dis. 2017 Jan 1;215(1):88-94. doi: 10.1093/infdis/jiw495. PMID: 28077587.

Slike BM, Creegan M, Marovich M, Ngauy V. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations. PLoS One. 2017 Jan 3;12(1):e0169247. doi: 10.1371/journal.pone.0169247. PMID: 28046039.